Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00172094 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
A Phase 2 study, sponsored by Shire.
- Completed
- Registry status
- Phase 2
- Development phase
- 189
- Enrollment target
NCT00172094: Completed Phase 2 study, sponsored by Shire.
NCT00172094 is a Phase 2 study that has completed, run by Shire. The registered enrollment target is 189 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00172094, a Phase 2 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 189 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.
Interventions
- DRUG PLACEBO
- DRUG NPS 1776 (800 mg)
- DRUG NPS 1776 (400 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2003-12-31 |
| Est. Completion | 2004-07-31 |
| Phase | Phase 2 |
What the finished NCT00172094 record still lists
NCT00172094 is an interventional study that assigns participants to a tested intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 3 interventions - of which PLACEBO is the first listed.
NCT00172094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00172094 about?
NCT00172094 is a clinical study titled "Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches". The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.
What is the current status of trial NCT00172094?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 189 participants. The study started on 2003-12-31. Estimated completion is 2004-07-31.
What interventions are being tested in trial NCT00172094?
The interventions under investigation include: PLACEBO (DRUG), NPS 1776 (800 mg) (DRUG), NPS 1776 (400 mg) (DRUG).
Who is sponsoring clinical trial NCT00172094?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00172094's enrollment target sits among peer trials
189 355th of 2000 higher than 1,645 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI